Journal of Heavy Metal Toxicity and Diseases Open Access

  • ISSN: 2473-6457
  • Journal h-index: 8
  • Journal CiteScore: 2.24
  • Journal Impact Factor: 1.46
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Reach us +32 25889658

Editorial - (2016) Volume 1, Issue 3

Which Strategies can be Adopted against Heavy Metal Intoxication?

Fulgenzi A and Ferrero ME*

Department of Biomedical Sciences for Health, University of Milan, Milan, Italy

*Corresponding Author:

Ferrero ME
Department of Biomedical Sciences for Health
University of Milan, Milan, Italy
Tel: 02503 15333
E-mail: mariaelena.ferrero@unimi.it

Received date: October 12, 2016; Accepted date: October 17, 2016; Published date: October 21, 2016

Citation: Fulgenzi A, Ferrero ME. Which strategies can be Adopted against Heavy Metal Intoxication? J Heavy Met Toxicity Dis. 2016, 1:3.

Copyright: © 2016 Fulgenzi A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Heavy Metal Toxicity and Diseases

Editorial

Much evidence exists showing heavy metals (mainly arsenic, lead, mercury, and cadmium) to be common environmental pollutants. They induce the interruption of intracellular homeostasis, causing damage to lipids, proteins, enzymes, and DNA through the production of oxygen and nitrogen free radicals. These products impair the balance between the pro-oxidant and antioxidant systems in the body: The shift towards the former is known as “oxidative stress”. Oxidative stress-mediated toxicity caused by heavy metals mainly involves the liver and kidneys, the central nervous system, and the endocrine system [1-4]. Which strategies can be adopted against the dangerous effects of toxic metals? The most commonly used strategy against heavy-metal poisoning is chelation therapy, which promotes metal excretion. This treatment is suggested following both acute and chronic intoxication, and can also be used to remove intoxication caused by a non-heavy metal, such as aluminum [4]. However, new strategies have recently been reported, describing the protective effects of dietary supplements against cadmium and lead toxicity [5]. Essential metals, vitamins, edible plants, phytochemicals, and probiotics have been proposed, in association with a selection of recommended food products. Moreover, evidence of sub-commissural organ involvement in the rat brain response to lead exposure, and the modulatory potential of curcumin, a polyphenolic natural compound with antioxidant and anti-inflammatory properties, have been described [6]. Neurodegenerative diseases have been associated to metal-induced neurotoxicity [7]. Several nutraceutical approaches have been proposed against neurodegeneration [8]. Neurodegenerative disorders are complex and multifactorial, involving pathways such as mitochondrial dysfunction, intracellular Ca2+ overload, oxidative stress, and inflammation. Food-based approaches are believed to target these pathways. Finally, since neuro-inflammation is generally associated to neurodegeneration, various pharmacologic targets of inflammation have been considered [9].

In our opinion, the first efficient treatment for toxic metal burden is chelation therapy with CaNa2 ethylenediaminetetraacetic acid (EDTA) for the following reasons:

EDTA is an important antioxidant compound. It has been shown to decrease oxidative DNA damage and lipid peroxidation [10].

EDTA efficiently removes all toxic metals present in the body, as shown by the results of chelation tests [5-12].

EDTA administration preserves kidney function [13,14].

EDTA chelation therapy can reduce cardiovascular events in patients with diabetes, because metals such as cadmium and lead are toxic for the cardiovascular system [14].

EDTA reaches the central nervous system and exerts a protective activity against endothelial cell activation [15].

References

  1. Jan AT, Azam M, Siddiqui K, Ali A, Choi I, et al. (2015) Heavy metals and human health: Mechanistic insight into toxicity and counter defense system of antioxidants. Int J Mol Sci 16:29592-29630.
  2. Sharma B, Singh S, Siddiqi NJ (2014) Biomedical implications of heavy metals induced imbalances in redox systems. Biomed Res Intpp: 1-26.
  3. Rana SVS (2014) Perspectives in endocrine toxicity of heavy metals - A review. Biol Trace Elem Res 160: 1-14.
  4. Fulgenzi A, Vietti D, Ferrero ME (2014) Aluminium involvement in neurotoxicity. Biomed Res Intpp: 1-5.
  5. Zhai Q, Narbad A, Chen W (2015) Dietary strategies for the treatment of cadmium and lead toxicity. Nutrients 7: 552-571.
  6. Benammi H, El Hiba O, Gamrani H (2016) Evidence of a subcommissural organ involvement in the brain response to lead exposure and a modulatory potential of curcumin. Neuroreport 27: 264-271.
  7. Zhang Z, Miah M, Culbreth M, Aschner M (2016) Autophagy in Neurodegenerative Diseases and Metal Neurotoxicity. Neurochem Res 41: 409-422.
  8. Dadhania VP, Trivedi PP, Vikram A, Tripathi DN (2016) Nutraceuticals against Neurodegeneration: A Mechanistic Insight. Curr Neuropharmacol 14: 627-640.
  9. de Oliveira ACP, Candelario-Jalil E, Fiebich BL, Santos M da S, Palotas A, et al. (2015) Neuroinflammation and Neurodegeneration: Pinpointing Pathological and Pharmacological Targets. Biomed Res Intpp: 487241-487242.
  10. Roussel AM, Hininger-Favier I, Waters RS, Osman M, Fernholz K, et al. (2009) EDTA Chelation therapy, without added vitamin C, decreases oxidative DNA damage and lipid peroxidation. Altern Med Rev 14: 56-61.
  11. Fulgenzi A, Zanella SG, Mariani MM, Vietti D, Ferrero ME (2012) A case of multiple sclerosis improvement following removal of heavy metal intoxication: lessons learnt from Matteo’s case. Biometals 25: 569-576.
  12. Foglieni C, Fulgenzi A, Ticozzi P, Pellegatta F, Sciorati C, et al. (2006) Protective effect of EDTA preadministration on renal ischemia. BMC Nephrol7: 1-12.
  13. Lin JL, Lin-Tan DT, Hsu KH, Yu CC (2003) Environmental lead exposure and progression of chronic renal diseases in patients without diabetes. NEJM 348: 277-286
  14. Ouyang P, Gottlieb SH, Culotta VL, Navas-Acien A (2015) EDTA Chelation Therapy to Reduce Cardiovascular Events in Persons with Diabetes. Curr Cardiol Rep17: 96-105.
  15. Fulgenzi A, Zito F, Marchelli D, Colombo F, Ferrero ME (2016) New insights into EDTA in vitro effects on endothelial cells and on in vivo labeled EDTA biodistribution. J Heavy Metal Toxicity Dis 1: 1-6.